Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BCAB

BioAtla Inc

May 14 • 09:38AM ET

4.42

+0.02 0.50 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: SABS IMNN BCTX BLRX HOTH

| Held by: VTI VXF BTEC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-50.76	Insider Own	18.72%	Shs Outstand	1.66M	Perf Week	1.66%
Market Cap	7.34M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.38M	Perf Month	-1.84%
Enterprise Value	10.56M	PEG	-	EPS next Q	-	Inst Own	10.47%	Short Float	10.67%	Perf Quarter	-46.30%
Income	-59.61M	P/S	3.67	EPS this Y	-	Inst Trans	-0.18%	Short Ratio	3.73	Perf Half Y	-87.03%
Sales	2.00M	P/B	-	EPS next Y	-	ROA	-176.84%	Short Interest	0.15M	Perf YTD	-84.42%
Book/sh	-28.51	P/C	1.03	EPS next 5Y	-	ROE	-813.88%	52W High	71.50 -93.82%	Perf Year	-78.40%
Cash/sh	4.29	P/FCF	-	EPS past 3/5Y	28.18% 0.99%	ROIC	-	52W Low	3.92 12.81%	Perf 3Y	-97.59%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- 36.06%	Gross Margin	81.35%	Volatility	9.95% 11.59%	Perf 5Y	-99.80%
Dividend TTM	-	EV/Sales	5.28	EPS Y/Y TTM	29.36%	Oper. Margin	-2965.25%	ATR (14)	0.56	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.37	Sales Y/Y TTM	-81.82%	Profit Margin	-2980.35%	RSI (14)	41.49	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.37	EPS Q/Q	45.09%	SMA20	-5.68%	Beta	0.80	Target Price	200.00
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-27.88%	Rel Volume	0.21	Prev Close	4.40
Employees	41	LT Debt/Eq	-	Earnings	Mar 31 AMC	SMA200	-80.23%	Avg Volume	39.47K	Price	4.42
IPO	Dec 16, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	853	Change	0.50%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)